India to Hungary: Meropenem Export Trade Route

The India to Hungary Meropenem corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $3.6M USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's meropenem manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $150.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with meropenem's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 26.9%, placing it at rank #11 among India's top meropenem export destinations globally.

On the import side, key buyers of Indian meropenem in Hungary include E P H K. E P H K is the single largest importer with 24 shipments valued at $3.6M USD.

India's meropenem exports to Hungary are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 24 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Hungary benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $150.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as meropenem 1.0 gm powder for solution forinjection or infusion(meropenem venus pharma 1.0 gm) and meropenem 1.0 gm powder for solution forinjection or infusion(meropenem venus pharma 1 gm), suggesting that buyers in Hungary tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, E P H K is the largest importer with 24 shipments worth $3.6M USD — representing 100% of all meropenem imports from India on this route.